US Broker Ratings

Sana Biotechnology (SANA) Stock Analysis: A Look at a Potential 172.77% Upside

Sana Biotechnology, Inc. (NASDAQ: SANA) presents an intriguing opportunity for investors with a taste for high-risk, high-reward plays in the healthcare sector. With a market capitalization..

COMPASS Pathways Plc (CMPS): Analyst Ratings Reveal a Promising 230% Upside for Innovative Mental Health Solutions

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotech firm at the forefront of mental health treatment, is drawing significant investor attention. With its innovative psilocybin therapy,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: A Look at Potential Upside Amidst Challenging Market Dynamics

Cross Country Healthcare, Inc. (NASDAQ: CCRN) operates within the dynamic healthcare sector, specifically in the medical care facilities industry. Headquartered in Boca Raton, Florida, the company..

Keros Therapeutics (KROS): Investor Outlook Reveals a 105% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS), a U.S.-based clinical-stage biopharmaceutical company, has been capturing the attention of investors with its promising pipeline and significant upside potential. Headquartered..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a Potential 73% Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a Switzerland-based biotechnology company, is gaining attention in the healthcare sector with its focus on therapies for rare diseases, particularly angioedema. This late-stage..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating the Healthcare Sector with a 1.47% Potential Upside

Enhabit, Inc. (EHAB), a key player in the healthcare sector, is steadily carving out its niche within the medical care facilities industry. With a market capitalization..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Biotech Gem with 117.2% Revenue Growth and 14.31% Potential Upside

Stoke Therapeutics, Inc. (NASDAQ: STOK), an innovative player in the biotechnology sector, has captured the attention of investors with its promising pipeline of treatments targeting severe..

InnovAge Holding Corp. (INNV): Investor Outlook Reveals a Potential 15.97% Downside Amidst Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV) stands at a pivotal juncture, presenting an intriguing case for investors who are eager to tap into the healthcare sector. As..

HealthStream, Inc. (HSTM) Stock Analysis: Evaluating Strong Upside Potential with a 50% Growth Outlook

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the health information services sector, is drawing attention from investors with its robust growth potential and solid market..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 13.99% Potential Upside in the Biotech Sector

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology industry with a promising potential upside of 13.99%. The company, based in South San Francisco, California,..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a Promising 11% Upside

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the U.S. healthcare sector, operates a vast network of general acute care hospitals and an array..

Immatics N.V. (IMTX) Stock Analysis: Exploring a Potential 107% Upside in Biotech

Immatics N.V. (IMTX), a German biopharmaceutical company listed on the NASDAQ, stands at the forefront of cancer research with its innovative T cell redirecting immunotherapies. Specializing..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A 41.90% Potential Upside Awaits Investors

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector’s medical devices industry, has carved out a niche by solely focusing on pediatric orthopedic conditions...

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet with 90% Upside Potential

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is carving out a niche in the burgeoning field of psychedelic-based therapies for brain health disorders. With a market capitalization..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating a 56% Potential Upside Amidst Volatility

Ginkgo Bioworks Holdings, Inc. (DNA) has recently captured the attention of investors with its intriguing potential upside of 56.25% against the backdrop of a volatile market..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 52.38% Upside Potential Amid Strong Buy Ratings

Bicara Therapeutics Inc. (NASDAQ: BCAX) stands out in the biotechnology sector with a promising portfolio focusing on bifunctional therapies for solid tumors. Based in Boston, Massachusetts,..

Bicycle Therapeutics plc (BCYC) Stock Analysis: A Biotechnology Innovator with 273% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC) stands at the forefront of the biotechnology sector, developing groundbreaking therapies aimed at some of the most challenging and underserved diseases...

Inventiva S.A. (IVA) Stock Analysis: Unpacking a 150% Potential Upside with Strong Buy Ratings

Inventiva S.A. – American Depositary Shares (IVA) is garnering attention in the biotechnology sector, standing out with a remarkable 150.95% potential upside as indicated by analyst..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Specialty Pharma with a 53.81% Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands as a compelling player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry. With a..

AxoGen, Inc. (AXGN) Stock Analysis: Navigating the 27.69% Upside Potential in the Healthcare Sector

In the competitive and rapidly evolving landscape of the healthcare sector, AxoGen, Inc. (NASDAQ: AXGN) is carving out a niche with its innovative solutions in peripheral..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds